IUCN event 28 Aug, 2024

One Health in Nature Conservation in Central Asia: Project kick-off and Regional Protected and Conserved Areas Orientation Workshop

The risk of zoonotic diseases in Central Asia is exacerbated by biodiversity loss and changes in human-wildlife interactions. As part of the new initiative, IUCN and national and international partners, including all five Central Asian countries, are implementing actions to prevent the emergence and spread of zoonotic diseases.

content hero image

The new project “One Health in Nature Conservation - Enhancing landscape resilience to zoonotic disease emergence by consolidating nature conservation systems in Central Asia” under the International Climate Initiative (IKI), implemented by IUCN and national and international partners will help prevent the emergence and spread of zoonotic diseases. The One Health approach is central to this project, and it integrates human, animal, and environmental health. 

Two-day hybrid event is co-hosted by the Ministry of Ecology, Environmental Protection and Climate Change of the Republic of Uzbekistan, and includes:

The agenda is available in English and Russian

To follow the event remotely via Zoom, please register here.

One Health in Nature Conservation in Central Asia project aims to mitigate the risk of zoonosis - diseases naturally transmissible from animals to humans - by expanding the extent and strengthening conservation measures in natural and overlapping sociocultural areas. It seeks to address the relevant causes of epidemic risk and consolidate a fair and effective regional network of protected and conserved areas (PCAs). The project is funded by the German Ministry for Environment, Nature Conservation, Nuclear Safety, and Consumer Protection (BMUV) through the International Climate Initiative (IKI) and executed by IUCN in collaboration with a consortium of national and international organizations across five Central Asian countries: Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan, over 5 years (2024-2029).